subject area of
- A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects Journal Articles
- Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma Journal Articles
- Canadian Standards Association Standard CAN/CSA/Z264.1‐02:2002: A New Voluntary Standard for Spacers and Holding Chambers Used with Pressurized Metered‐Dose Inhalers Journal Articles
- Clinical equivalence testing of inhaled bronchodilators Journal Articles
- Clinically Relevant Test Methods to EstablishIn VitroEquivalence for Spacers and Valved Holding Chambers Used with Pressurized Metered Dose Inhalers (pMDIs) Journal Articles
- Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines Journal Articles
- Epinephrine metered‐dose inhaler for pediatric croup Journal Articles
- Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report Journal Articles
- Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review Journal Articles
- Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age Journal Articles
- Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging study Journal Articles
- Metered‐dose inhaler ipratropium bromide in moderate acute asthma in children: A single‐blinded randomised controlled trial Journal Articles
- Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma Journal Articles
- Perceptual Reasons for Resistance to Change in the Emergency Department Use of Holding Chambers for Children With Asthma Journal Articles
- Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications Journal Articles
- Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study Journal Articles